291 related articles for article (PubMed ID: 34561270)
41. Combination anti-CXCR4 and anti-PD-1 immunotherapy provides survival benefit in glioblastoma through immune cell modulation of tumor microenvironment.
Wu A; Maxwell R; Xia Y; Cardarelli P; Oyasu M; Belcaid Z; Kim E; Hung A; Luksik AS; Garzon-Muvdi T; Jackson CM; Mathios D; Theodros D; Cogswell J; Brem H; Pardoll DM; Lim M
J Neurooncol; 2019 Jun; 143(2):241-249. PubMed ID: 31025274
[TBL] [Abstract][Full Text] [Related]
42. Advances in immunotherapy for glioblastoma multiforme.
Mahmoud AB; Ajina R; Aref S; Darwish M; Alsayb M; Taher M; AlSharif SA; Hashem AM; Alkayyal AA
Front Immunol; 2022; 13():944452. PubMed ID: 36311781
[TBL] [Abstract][Full Text] [Related]
43. Human gamma-delta (γδ) T cell therapy for glioblastoma: A novel alternative to overcome challenges of adoptive immune cell therapy.
Choi H; Kim TG; Jeun SS; Ahn S
Cancer Lett; 2023 Sep; 571():216335. PubMed ID: 37544475
[TBL] [Abstract][Full Text] [Related]
44. Biomarkers for immunotherapy for treatment of glioblastoma.
Lynes JP; Nwankwo AK; Sur HP; Sanchez VE; Sarpong KA; Ariyo OI; Dominah GA; Nduom EK
J Immunother Cancer; 2020 May; 8(1):. PubMed ID: 32474411
[TBL] [Abstract][Full Text] [Related]
45. Advances in research on immune escape mechanism of glioma.
Guo X; Wang G
CNS Neurosci Ther; 2023 Jul; 29(7):1709-1720. PubMed ID: 37088950
[TBL] [Abstract][Full Text] [Related]
46. Co-inhibitory blockade while preserving tolerance: checkpoint inhibitors for glioblastoma.
Lucca LE; Hafler DA
Immunol Rev; 2017 Mar; 276(1):9-25. PubMed ID: 28258696
[TBL] [Abstract][Full Text] [Related]
47. Immunotherapy of glioblastoma: Recent advances and future prospects.
Yuan B; Wang G; Tang X; Tong A; Zhou L
Hum Vaccin Immunother; 2022 Nov; 18(5):2055417. PubMed ID: 35344682
[TBL] [Abstract][Full Text] [Related]
48. Advances in immunotherapy for the treatment of glioblastoma.
Tivnan A; Heilinger T; Lavelle EC; Prehn JH
J Neurooncol; 2017 Jan; 131(1):1-9. PubMed ID: 27743144
[TBL] [Abstract][Full Text] [Related]
49. The CNS and the Brain Tumor Microenvironment: Implications for Glioblastoma Immunotherapy.
Desland FA; Hormigo A
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33027976
[TBL] [Abstract][Full Text] [Related]
50. Current state and future of co-inhibitory immune checkpoints for the treatment of glioblastoma.
Shen S; Chen L; Liu J; Yang L; Zhang M; Wang L; Zhang R; Uemura Y; Wu Q; Yu X; Liu T
Cancer Biol Med; 2020 Aug; 17(3):555-568. PubMed ID: 32944390
[TBL] [Abstract][Full Text] [Related]
51. Temozolomide treatment outcomes and immunotherapy efficacy in brain tumor.
Hotchkiss KM; Sampson JH
J Neurooncol; 2021 Jan; 151(1):55-62. PubMed ID: 32813186
[TBL] [Abstract][Full Text] [Related]
52. Immunotherapy for Neuro-oncology.
Majd NK; Dasgupta PR; de Groot JF
Adv Exp Med Biol; 2021; 1342():233-258. PubMed ID: 34972967
[TBL] [Abstract][Full Text] [Related]
53. Advances in Immunotherapies for Gliomas.
Zhang M; Choi J; Lim M
Curr Neurol Neurosci Rep; 2022 Jan; 22(1):1-10. PubMed ID: 35107784
[TBL] [Abstract][Full Text] [Related]
54. Challenges in glioblastoma immunotherapy: mechanisms of resistance and therapeutic approaches to overcome them.
Habashy KJ; Mansour R; Moussalem C; Sawaya R; Massaad MJ
Br J Cancer; 2022 Oct; 127(6):976-987. PubMed ID: 35662275
[TBL] [Abstract][Full Text] [Related]
55. Perspectives on Microglia-Based Immune Therapies Against Glioblastoma.
Rivera M; Bander ED; Cisse B
World Neurosurg; 2021 Oct; 154():228-231. PubMed ID: 34583500
[TBL] [Abstract][Full Text] [Related]
56. T-Cell based therapies for overcoming neuroanatomical and immunosuppressive challenges within the glioma microenvironment.
Kwok D; Okada H
J Neurooncol; 2020 Apr; 147(2):281-295. PubMed ID: 32185647
[TBL] [Abstract][Full Text] [Related]
57. Developing immunotherapeutic strategies to target brain tumors.
Lieberman NA; Moyes KW; Crane CA
Expert Rev Anticancer Ther; 2016 Jul; 16(7):775-88. PubMed ID: 27253692
[TBL] [Abstract][Full Text] [Related]
58. Challenges in the Treatment of Glioblastoma: Multisystem Mechanisms of Therapeutic Resistance.
Noch EK; Ramakrishna R; Magge R
World Neurosurg; 2018 Aug; 116():505-517. PubMed ID: 30049045
[TBL] [Abstract][Full Text] [Related]
59. Novel mechanisms and approaches in immunotherapy for brain tumors.
Finocchiaro G; Pellegatta S
Discov Med; 2015; 20(108):7-15. PubMed ID: 26321082
[TBL] [Abstract][Full Text] [Related]
60. Neoantigen discovery and applications in glioblastoma: An immunotherapy perspective.
Wang C; Yu M; Zhang W
Cancer Lett; 2022 Dec; 550():215945. PubMed ID: 36216148
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]